{"id":780961,"date":"2023-08-30T10:05:14","date_gmt":"2023-08-30T14:05:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\/"},"modified":"2023-08-30T10:05:14","modified_gmt":"2023-08-30T14:05:14","slug":"cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\/","title":{"rendered":"Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September"},"content":{"rendered":"<div class=\"mw_release\">\n<p>PHILADELPHIA, Aug.  30, 2023  (GLOBE NEWSWIRE) &#8212; Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today announced that the Company will participate in four upcoming investor conferences in September:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>2023 Wells Fargo Healthcare Conference:<\/strong> Members of management will be available for one-on-one meetings on Wednesday, September 6, 2023 in Boston, MA.<\/p>\n<\/li>\n<li>\n          <strong>Citi\u2019s 18th Annual BioPharma Conference: <\/strong>Gwendolyn Binder, Ph.D., President of Science and Technology, will participate in a panel discussion titled \u201cCell Therapies in Autoimmune\u201d on Thursday, September 7, 2023 at 1:50 p.m. ET in Boston, MA. Members of management will also be available for one-on-one meetings.<\/p>\n<\/li>\n<li>\n          <strong>H.C. Wainwright 25th Annual Global Investment Conference: <\/strong>Steven Nichtberger, M.D., Chief Executive Officer, will participate in a fireside chat on Wednesday, September 13, 2023 at 8:30 a.m. ET in New York, NY. Members of management will also be available for one-on-one meetings.<\/p>\n<\/li>\n<li>\n          <strong>Morgan Stanley 21st Annual Global Healthcare Conference: <\/strong>Steven Nichtberger, M.D., Chief Executive Officer, will participate in a fireside chat on Wednesday, September 13, 2023 at 2:15 p.m. ET in New York, NY. Members of management will also be available for one-on-one meetings.<\/li>\n<\/ul>\n<p>A live webcast of the presentations will be available on the News and Events section of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1_XC7OQ1QLqC-KZbA5e55Lm2Xre_374SW-b4Pcgl8QWi4v6scvV_B2hEkIRGe8V9RSWcST-vZum0N2-Bi1tCCf384mrd3I8DKHQYGEd-XHM=\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.cabalettabio.com<\/u><\/a>. Replays will be available on the website for 30 days.<\/p>\n<p>\n        <strong>About Cabaletta Bio<\/strong><br \/>\n        <br \/>Cabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies that have the potential to provide a deep and durable, perhaps curative, treatment for patients with autoimmune diseases. The CABA\u2122 platform encompasses two strategies: the CARTA (chimeric antigen receptor T cells for autoimmunity) strategy, with CABA-201, a 4-1BB-containing fully human CD19-CAR T, as the lead product candidate being evaluated in systemic lupus erythematosus and myositis, and the CAART (chimeric autoantibody receptor T cells) strategy, with multiple clinical-stage candidates, including DSG3-CAART for mucosal pemphigus vulgaris and MuSK-CAART for MuSK myasthenia gravis. The expanding CABA\u2122 platform is designed to develop potentially curative therapies that offer deep and durable responses for patients with a broad range of autoimmune diseases. Cabaletta Bio\u2019s headquarters and labs are located in Philadelphia, PA.<\/p>\n<p>\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p>Anup Marda<br \/>Chief Financial Officer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SsSL6jukLOovC86iRHpA1efHdVnU84fabHJyAg3ZrPzK2x1UdRKlcWfPLF15kWJ_XMnd2PdBaUOsjKAoi-A0z74oJauYPYhpohg-u8B6KGTnz0meUKBOGD6ko_YuH3OF\" rel=\"nofollow noopener\" target=\"_blank\"><u>investors@cabalettabio.com<\/u><\/a><\/p>\n<p>William Gramig<br \/>Stern Investor Relations, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0a_kS8hl7zEdMkqpPhKaCVapo9Uyy_Iiv8B9Z9iVz2WoMEkByS9NVi43G_VXPrn8wVMfB-hNY3AdpQBgvFdmY85vpKe2_d46W_Iek0y0u8zE6zFbjOBmHTE0UeWAuhDZ\" rel=\"nofollow noopener\" target=\"_blank\">william.gramig@sternir.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzAyMiM1Nzg4OTQwIzIxMjUwMzA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjhiNDQzOTEtOWM5NS00ZjU2LWIzNTAtYjBlY2Q0MTM2YTMxLTExMzY2MDE=\/tiny\/Cabaletta-Bio.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PHILADELPHIA, Aug. 30, 2023 (GLOBE NEWSWIRE) &#8212; Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today announced that the Company will participate in four upcoming investor conferences in September: 2023 Wells Fargo Healthcare Conference: Members of management will be available for one-on-one meetings on Wednesday, September 6, 2023 in Boston, MA. Citi\u2019s 18th Annual BioPharma Conference: Gwendolyn Binder, Ph.D., President of Science and Technology, will participate in a panel discussion titled \u201cCell Therapies in Autoimmune\u201d on Thursday, September 7, 2023 at 1:50 p.m. ET in Boston, MA. Members of management will also be available for one-on-one meetings. H.C. Wainwright 25th Annual Global Investment &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-780961","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA, Aug. 30, 2023 (GLOBE NEWSWIRE) &#8212; Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today announced that the Company will participate in four upcoming investor conferences in September: 2023 Wells Fargo Healthcare Conference: Members of management will be available for one-on-one meetings on Wednesday, September 6, 2023 in Boston, MA. Citi\u2019s 18th Annual BioPharma Conference: Gwendolyn Binder, Ph.D., President of Science and Technology, will participate in a panel discussion titled \u201cCell Therapies in Autoimmune\u201d on Thursday, September 7, 2023 at 1:50 p.m. ET in Boston, MA. Members of management will also be available for one-on-one meetings. H.C. Wainwright 25th Annual Global Investment &hellip; Continue reading &quot;Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-30T14:05:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzAyMiM1Nzg4OTQwIzIxMjUwMzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September\",\"datePublished\":\"2023-08-30T14:05:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\\\/\"},\"wordCount\":396,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzAyMiM1Nzg4OTQwIzIxMjUwMzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\\\/\",\"name\":\"Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzAyMiM1Nzg4OTQwIzIxMjUwMzA=\",\"datePublished\":\"2023-08-30T14:05:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzAyMiM1Nzg4OTQwIzIxMjUwMzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkxMzAyMiM1Nzg4OTQwIzIxMjUwMzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\/","og_locale":"en_US","og_type":"article","og_title":"Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September - Market Newsdesk","og_description":"PHILADELPHIA, Aug. 30, 2023 (GLOBE NEWSWIRE) &#8212; Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today announced that the Company will participate in four upcoming investor conferences in September: 2023 Wells Fargo Healthcare Conference: Members of management will be available for one-on-one meetings on Wednesday, September 6, 2023 in Boston, MA. Citi\u2019s 18th Annual BioPharma Conference: Gwendolyn Binder, Ph.D., President of Science and Technology, will participate in a panel discussion titled \u201cCell Therapies in Autoimmune\u201d on Thursday, September 7, 2023 at 1:50 p.m. ET in Boston, MA. Members of management will also be available for one-on-one meetings. H.C. Wainwright 25th Annual Global Investment &hellip; Continue reading \"Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-30T14:05:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzAyMiM1Nzg4OTQwIzIxMjUwMzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September","datePublished":"2023-08-30T14:05:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\/"},"wordCount":396,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzAyMiM1Nzg4OTQwIzIxMjUwMzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\/","name":"Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzAyMiM1Nzg4OTQwIzIxMjUwMzA=","datePublished":"2023-08-30T14:05:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzAyMiM1Nzg4OTQwIzIxMjUwMzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkxMzAyMiM1Nzg4OTQwIzIxMjUwMzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cabaletta-bio-to-participate-in-multiple-upcoming-investor-conferences-in-september\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/780961","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=780961"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/780961\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=780961"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=780961"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=780961"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}